TrialPhase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
Trial details
- Registry ID
- NCT07287189
- Phase
- Phase 2
Drug research
SAT-3247
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2 Study of SAT-3247 in Pediatric Ambulatory PatientsNCT07287189 | MSLE | Phase 2 | Recruiting | 2027-03-31Estimated |
| An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101NCT06867107 | MSLE | Phase 2 | Enrolling by invitation | 2027-09-30Estimated |
An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101
Trial details
- Registry ID
- NCT06867107
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |